902 related articles for article (PubMed ID: 11981591)
1. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
2. Cataleptic effect of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice: modulation by serotonergic agents.
Deshpande LS; Khisti RT; Chopde CT
Brain Res; 2001 Apr; 898(1):13-26. PubMed ID: 11292445
[TBL] [Abstract][Full Text] [Related]
3. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
[TBL] [Abstract][Full Text] [Related]
4. Adenosinergic modulation of 3alpha-hydroxy-5alpha-pregnan-20-one induced catalepsy in mice.
Mandhane SN; Khisti RT; Chopde CT
Psychopharmacology (Berl); 1999 Jun; 144(4):398-404. PubMed ID: 10435413
[TBL] [Abstract][Full Text] [Related]
5. Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats.
Jain NS; Hirani K; Chopde CT
Neuropharmacology; 2005 Apr; 48(5):627-38. PubMed ID: 15814098
[TBL] [Abstract][Full Text] [Related]
6. Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines.
Barbaccia ML; Carai MA; Colombo G; Lobina C; Purdy RH; Gessa GL
Neuropharmacology; 2005 Jul; 49(1):48-58. PubMed ID: 15992580
[TBL] [Abstract][Full Text] [Related]
7. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
Ugale RR; Hirani K; Morelli M; Chopde CT
Neuropsychopharmacology; 2004 Sep; 29(9):1597-609. PubMed ID: 15100702
[TBL] [Abstract][Full Text] [Related]
8. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
9. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
[TBL] [Abstract][Full Text] [Related]
10. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
11. Partial agonism by 3alpha,21-dihydroxy-5beta-pregnan-20-one at the gamma-aminobutyric acidA receptor neurosteroid site.
Xue BG; Whittemore ER; Park CH; Woodward RM; Lan NC; Gee KW
J Pharmacol Exp Ther; 1997 Jun; 281(3):1095-101. PubMed ID: 9190841
[TBL] [Abstract][Full Text] [Related]
12. Progestins' actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors.
Frye CA; Walf AA; Sumida K
Pharmacol Biochem Behav; 2004 Jul; 78(3):405-18. PubMed ID: 15251249
[TBL] [Abstract][Full Text] [Related]
13. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice.
Akhtar M; Uma Devi P; Ali A; Pillai KK; Vohora D
Fundam Clin Pharmacol; 2006 Aug; 20(4):373-8. PubMed ID: 16867021
[TBL] [Abstract][Full Text] [Related]
15. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one.
Hirani K; Khisti RT; Chopde CT
Neuropharmacology; 2002 Dec; 43(8):1339-50. PubMed ID: 12527484
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
17. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats.
Hirani K; Sharma AN; Jain NS; Ugale RR; Chopde CT
Psychopharmacology (Berl); 2005 Jul; 180(2):267-78. PubMed ID: 15719223
[TBL] [Abstract][Full Text] [Related]
19. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic ethanol consumption and withdrawal on the neuroactive steroid 3alpha-hydroxy-5alpha-pregnan-20-one in male and female rats.
Janis GC; Devaud LL; Mitsuyama H; Morrow AL
Alcohol Clin Exp Res; 1998 Dec; 22(9):2055-61. PubMed ID: 9884151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
